Literature DB >> 15756576

An optimised protocol for the production of autologous serum eyedrops.

L Liu1, D Hartwig, S Harloff, P Herminghaus, T Wedel, G Geerling.   

Abstract

BACKGROUND: Serum eyedrops have been successfully used in the treatment of severe dry eye, persistent epithelial defects and other severe ocular surface disorders. A number of clinical studies showed a variable efficacy of this approach, but the parameters for the production of this blood product varied significantly. In order to establish an optimised protocol for the production of serum eyedrops, we examined the effect of various clotting times, centrifugation forces, types of diluent and dilutions on the concentration of growth factors, fibronectin, and vitamins in serum and tested the epitheliotrophic capacity of these serum modifications in a cell culture model of human SV-40-immortalised corneal epithelial cells (HCE-T).
METHODS: Serum samples were prepared with a clotting time of 20, 60 or 120 min, a centrifugation force of 500 xg or 3,000 xg, and diluted with BSS or isotonic saline. The concentrations of EGF, TGF-beta1, PDGF-AB, FGF, HGF, fibronectin, vitamin A and vitamin E in these samples were evaluated with ELISA and HPLC. HCE-T cells were incubated for 24, 48, 72, 96 and 144 h with 100, 50, 25, 12.5, 6.25 and 3.125% serum in diluent, and cell proliferation, migration and differentiation were evaluated by means of a luminescence-based ATP assay, a colony-dispersion assay and scanning electron microscopy.
RESULTS: Using a longer clotting time resulted in an increased concentration of all the epitheliotrophic factors examined in serum; the difference was statistically significant for EGF, TGF-beta1 and HGF. Increasing the g force of centrifugation from 500 xg to 3,000 xg resulted in significantly less TGF-beta1, but more EGF and vitamin A. Cell proliferation was better supported by serum prepared with 3,000 xg and diluted with BSS. Serum prepared with a longer clotting time yielded better cell migration and differentiation.
CONCLUSION: Clotting time, centrifugation and diluents have a significant impact on the composition and epitheliotrophic effects of serum. A long clotting time (>or=120 min), a sharp centrifugation (3,000 xg for 15 min) and dilution with BSS improve the ability of serum eyedrops to support proliferation, migration and differentiation of corneal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756576     DOI: 10.1007/s00417-004-1106-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  44 in total

1.  Fate of human keratinocytes during reepithelialization in an organotypic culture model.

Authors:  J A Garlick; L B Taichman
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

2.  The corneal and conjunctival surface in vitamin A deficiency: a scanning electron microscopy study.

Authors:  R R Pfister; M E Renner
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-09       Impact factor: 4.799

3.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

4.  TGF-beta s stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts.

Authors:  E P Kay; M S Lee; G J Seong; Y G Lee
Journal:  Curr Eye Res       Date:  1998-03       Impact factor: 2.424

5.  Induction of apoptosis in human corneal epithelial cells in vitro.

Authors:  J M Kim; F Stapleton; M D Willcox
Journal:  Aust N Z J Ophthalmol       Date:  1999 Jun-Aug

6.  Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy.

Authors:  K Bilgihan; U Adiguzel; C Sezer; G Akyol; B Hasanreisoglu
Journal:  Ophthalmologica       Date:  2001 May-Jun       Impact factor: 3.250

7.  Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface.

Authors:  Eduardo M Rocha; Daniel A Cunha; Everardo M Carneiro; Antonio C Boschero; Mário J A Saad; Lício A Velloso
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Transforming growth factor-beta modulates effects of epidermal growth factor on corneal epithelial cells.

Authors:  H Mishima; M Nakamura; J Murakami; T Nishida; T Otori
Journal:  Curr Eye Res       Date:  1992-07       Impact factor: 2.424

9.  Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing.

Authors:  Marion Haber; Zhiyi Cao; Noorjahan Panjwani; Daniela Bedenice; William W Li; Patricia J Provost
Journal:  Vet Ophthalmol       Date:  2003-09       Impact factor: 1.644

10.  The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix.

Authors:  B K Pilcher; J A Dumin; B D Sudbeck; S M Krane; H G Welgus; W C Parks
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

View more
  35 in total

1.  Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.

Authors:  Stefan Schrader; Thilo Wedel; Ralf Moll; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-17       Impact factor: 3.117

2.  [On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].

Authors:  K Kasper; L Godenschweger; D Hartwig; J D Unterlauft; B Seitz; G Geerling
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

3.  Autologous plasma eyedrops prepared in a closed system: a treatment for dry eye.

Authors:  A Petznick; L Tong; R Chung; J C Wang; M Koh; R Salleh; S Waduthantri
Journal:  Eye (Lond)       Date:  2013-05-31       Impact factor: 3.775

Review 4.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

Review 5.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

6.  Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro.

Authors:  Ming-Feng Wu; Tanja Stachon; Berthold Seitz; Achim Langenbucher; Nóra Szentmáry
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 7.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

Review 8.  [Ophthalmological complications in Sjögren's syndrome].

Authors:  C Jacobi; C Cursiefen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 9.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

Review 10.  Corneal nerves in health and disease.

Authors:  Brittany Simmons Shaheen; May Bakir; Sandeep Jain
Journal:  Surv Ophthalmol       Date:  2014-01-23       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.